Factor viii purification process
AssigneeAlpha Therapeutic Corporation
InventorsPrabir Bhattacharva, Toshiharu Motokubota
Life of this patent
Estimating the term…
Loading patent…
AssigneeAlpha Therapeutic Corporation
InventorsPrabir Bhattacharva, Toshiharu Motokubota
Estimating the term…
There is provided in accordance with the practice of this invention a process for separating Factor VIII complex from an impure protein fraction containing Factor VIII complex. An aqueous solution of the impure protein fraction containing Factor VIII complex is applied to a heparin-coupled chromatographic medium, to bind the Factor VIII complex to the medium. The Factor VIII is then recovered from the heparin-coupled chromatographic medium by elution with an aqueous solution comprising CaCl.sub.2 and histidine. The recovered Factor VIII is further purified by precipitation with a solution comprising glycine and NaCl, and washing the resultant precipitate with a solution comprising histidine, glycine, and NaCl to provide a Factor VIII complex solution with a specific activity of about 70 to about 150 units/mg.
A process for separating Factor VIII complex from an impure protein fraction containing Factor VIII complex, the process comprising the steps of:
A process for separating Factor VIII complex from an impure protein fraction containing Factor VIII complex, comprising the steps of:
Dependencies are inferred from the claim text.